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1. INTRODUCTION {#jcmm13538-sec-0001}
===============

Acute radiation exposure often leads to serve damages to radiosensitive tissues, which limit the use of radiotherapy in clinic.[1](#jcmm13538-bib-0001){ref-type="ref"}, [2](#jcmm13538-bib-0002){ref-type="ref"}, [3](#jcmm13538-bib-0003){ref-type="ref"} Haematopoietic system is vulnerable to ionizing radiation (IR), and the failure of haematopoietic system is the major reason of death after acute radiation exposure.[4](#jcmm13538-bib-0004){ref-type="ref"}, [5](#jcmm13538-bib-0005){ref-type="ref"} Radiation‐induced injury is a complex pathophysiological process.[6](#jcmm13538-bib-0006){ref-type="ref"}, [7](#jcmm13538-bib-0007){ref-type="ref"} In general, DNA is the critical target of ionizing radiation. DNA damage caused by IR mediates inflammasome activation and cell death.[8](#jcmm13538-bib-0008){ref-type="ref"}, [9](#jcmm13538-bib-0009){ref-type="ref"}, [10](#jcmm13538-bib-0010){ref-type="ref"}

Toll‐like receptors (TLRs) play essential roles in recognizing specific components of pathogenic microorganisms and triggering immune system responses.[11](#jcmm13538-bib-0011){ref-type="ref"}, [12](#jcmm13538-bib-0012){ref-type="ref"}, [13](#jcmm13538-bib-0013){ref-type="ref"}, [14](#jcmm13538-bib-0014){ref-type="ref"} In recent years, TLRs bring a new development direction to radioprotection. TLR2, TLR4, TLR5 and TLR9 have critical roles in radio‐resistance.[4](#jcmm13538-bib-0004){ref-type="ref"}, [15](#jcmm13538-bib-0015){ref-type="ref"}, [16](#jcmm13538-bib-0016){ref-type="ref"}, [17](#jcmm13538-bib-0017){ref-type="ref"}, [18](#jcmm13538-bib-0018){ref-type="ref"} In previous study, we showed that Zymosan‐A protected mice from radiation‐induced death, promoted cell viability and inhibited cell apoptosis caused by radiation *in vitro*. Using knockout mice, we proved that the radioprotective effects of Zymosan‐A were dependent on the TLR2 signalling pathway.[19](#jcmm13538-bib-0019){ref-type="ref"} In addition, we found that Zymosan‐A mitigated the damage of haematopoietic system and accelerated the recovery of haematopoiesis in mice. However, the potential mechanism is still unclear.

In this study, the molecular mechanism of radioprotection of Zymosan‐A was studied using flow cytometry, γ‐H2AX foci assay and RNA‐seq. Our experiments provided new knowledge regarding the radioprotective effect of Zymosan‐A.

2. MATERIALS AND METHODS {#jcmm13538-sec-0002}
========================

2.1. Chemicals and reagents {#jcmm13538-sec-0003}
---------------------------

Zymosan‐A was purchased from Sigma--Aldrich Corp (St. Louis, MO, USA), and normal saline (NS) was obtained from ChangHai Hospital (Shanghai, China). The apoptosis detection kit was purchased from Invitrogen (Carlsbad, CA, USA). Anti‐Mouse GM‐CSF‐PE, Anti‐Mouse G‐CSF‐eFluor 660, Anti‐Mouse IL‐6‐PerCP‐eFluor 710, Anti‐Mouse IL‐12‐PE were purchased from BD‐Pharmingen (San Diego, CA, USA).

2.2. Cell culture and treatment {#jcmm13538-sec-0004}
-------------------------------

Human B lymphocyte (AHH‐1)) was obtained from American Type Culture Collection, and cultured in RPMI 1640 with 10% FBS at 37°C in a 5% CO2 humidified chamber. Cells were treated with Zymosan‐A (40 μg/mL) 12 and 2 hours before irradiation.

2.3. Animals and treatment {#jcmm13538-sec-0005}
--------------------------

Male wild‐type C57BL/6 mice aged 6‐8 weeks were obtained from Chinese Academy of Sciences (Shanghai, China). All mice were housed in a laboratory animal room under standard conditions. The experiments were approved by the Laboratory Animal Center of the Second Military Medical University, China in conformance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The mice were treated with Zymosan‐A (50 mg/kg, dissolved in NS) via peritoneal injection 24 and 2 hours before ionizing radiation. Mice were sacrificed by cervical dislocation at different time after radiation.

2.4. Irradiation {#jcmm13538-sec-0006}
----------------

^60^Co source in the radiation centre (Faculty of Naval Medicine, Second Military Medical University, China) was used to irradiate mice and cells. Mice were irradiated at 7.5 Gy, and cells were irradiated at 8.0 Gy at the rate of 1 Gy/min.

2.5. Antibody staining and flow cytometry {#jcmm13538-sec-0007}
-----------------------------------------

Bone marrow cells (BMCs) were isolated freshly. Then, cells were strained through a 40‐μm strainer in the presence of phosphate‐buffered saline and red blood cells were removed. Cells were stained with antibody for 20 minutes at 4°C. The cell apoptosis was analysed using the apoptosis detection kit according to the manufacturer\'s instructions. PI and Annexin V were used to stain BMCs. BMCs were fixed, permeabilized and labelled with anti‐G‐CSF, anti‐GM‐CSF, anti‐IL‐6 and anti‐IL‐12 and then subjected to flow cytometry analysis.

2.6. Immunofluorescence analysis {#jcmm13538-sec-0008}
--------------------------------

Immunofluorescence analysis was used to detect γ‐H2AX foci. AHH‐1 cells were seeded in 6‐well plates at the concentration of 2\*10^5^ per well. Then, cells were treated with Zymosan‐A (40 μg/mL) 12 and 2 hours before 6 Gy irradiation. Then 0, 0.5, 2 hours later, cells were fixed in 4% paraformaldehyde for 20 minutes and permeabilized in 0.5% Triton X‐100 for 10 minutes. After blocked in BSA, cells were stained with γ‐H2AX, and then stained with the secondary antibody (1:1000). The images of cell smears were obtained using an Olympus BX60 fluorescent microscope (Olympus America Inc., Center Valley, PA, USA) equipped with a Retiga 2000R digital camera (Q Imaging Inc., Surrey, BC, Canada).

2.7. RNA sequencing and functional enrichment analysis {#jcmm13538-sec-0009}
------------------------------------------------------

Total RNA was isolated from BMCs using Trizol (Invitrogen, USA) 24 hours after radiation. NanoVue (GE, USA) was used to assess RNA purity. Each RNA sample had an A260:A280 ratio greater than 1.8 and an A260:A230 ratio \>2.0. RNA integrity was assessed using the Agilent 2200 Tape Station (Agilent Technologies, USA), and each sample had an RIN above 7.0. Briefly, mRNAs were isolated from the total RNA and fragmented to approximately 200 bp. Next, the collected mRNAs were subjected to first strand and second strand cDNA synthesis followed by adaptor ligation and enrichment with a low cycle according to the instructions provided with the TruSeq RNA LT/HT Sample Prep Kit (Illumina, USA). The purified library products were evaluated using the Agilent 2200 Tape Station and Qubit 2.0 (Life Technologies, USA). Sequencing was performed at Guangzhou Ribo Bio Co., Ltd. with the Illumina HiSeq 2500. Prior to sequencing, the raw data were filtered to produce high‐quality clean data. All the subsequent analyses were performed with the clean data. All the differentially expressed genes (DEGs) were used for heat map analysis, Gene Ontology Analysis and KEGG ontology enrichment analyses. For KEGG enrichment analysis, a *P*‐value \< .05 was used as the threshold to determine significant enrichment of the gene sets.

2.8. Statistical analysis {#jcmm13538-sec-0010}
-------------------------

Data were expressed as means ± standard deviation (SD). Two‐tailed Student\'s *t* test was used to analyse the difference between 2 groups. These data were analysed using SPSS ver. 19 (IBM Corp., Armonk, NY, USA). *P* \< .05 was considered statistically significant.

3. RESULTS {#jcmm13538-sec-0011}
==========

3.1. Zymosan‐A inhibited BMCs apoptosis caused by radiation {#jcmm13538-sec-0012}
-----------------------------------------------------------

The mortality of mice after radiation was associated with a serious and continuous BMCs loss.[16](#jcmm13538-bib-0016){ref-type="ref"} In previous study, we showed that Zymosan‐A significantly improved the number of BMCs after ionizing radiation.[19](#jcmm13538-bib-0019){ref-type="ref"} To explore the potential mechanism, we detected the apoptosis of BMCs 24 hours after radiation. The results showed that the BMCs apoptosis rate increased after radiation, while the apoptosis rate was decreased significantly in BMCs from mice which treated with Zymosan‐A (Figure [1](#jcmm13538-fig-0001){ref-type="fig"}).

![Zymosan‐A inhibited bone marrow cells (BMCs) apoptosis. (A) BMCs were isolated from mice 24 h after 7.5 Gy total body irradiation, and then the apoptosis of BMCs was analysed by flow cytometry. (B) Data are presented as mean ± SD of 3 independent experiments.](JCMM-22-2413-g001){#jcmm13538-fig-0001}

3.2. Zymosan‐A up‐regulated the levels of GM‐CSF, G‐CSF, IL‐12 and IL‐6 in BMCs {#jcmm13538-sec-0013}
-------------------------------------------------------------------------------

The protective effects of GM‐CSF, G‐CSF, IL‐12 and IL‐6 have been proven in several studies.[20](#jcmm13538-bib-0020){ref-type="ref"}, [21](#jcmm13538-bib-0021){ref-type="ref"}, [22](#jcmm13538-bib-0022){ref-type="ref"} Those cytokines play important roles in the haematopoietic system.[23](#jcmm13538-bib-0023){ref-type="ref"}, [24](#jcmm13538-bib-0024){ref-type="ref"} Using flow cytometry, we found that Zymosan‐A up‐regulated the levels of GM‐CSF, G‐CSF, IL‐12 and IL‐6 in BMCs (Figure [2](#jcmm13538-fig-0002){ref-type="fig"}).

![Zymosan‐A up‐regulated the level of GM‐CSF, G‐CSF, IL‐12 and IL‐6 in bone marrow cells (BMCs). BMCs were isolated from mice 24 h after radiation, and then the cytokines of BMCs were analysed by flow cytometry. (B) Data are presented as mean ± SD of 3 independent experiments.](JCMM-22-2413-g002){#jcmm13538-fig-0002}

3.3. Zymosan‐A protected cells from radiation‐induced DNA damage {#jcmm13538-sec-0014}
----------------------------------------------------------------

DNA is a critical target of ionizing radiation. DNA damage caused by IR mediates inflammasome activation and cell death.[9](#jcmm13538-bib-0009){ref-type="ref"} The γ‐H2AX foci analysis was used to detect the effect on DNA repair of Zymosan‐A. This result demonstrated that Zymosan‐A reduced the number of γ‐H2AX foci per cell at 0, 0.5 and 2 hours after irradiation (Figure [3](#jcmm13538-fig-0003){ref-type="fig"}).

![Zymosan‐A protected cells from radiation‐induced DNA damage. AHH‐1 Cells were irradiated at 8.0 Gy, and then the γH2AX foci were analysed.](JCMM-22-2413-g003){#jcmm13538-fig-0003}

3.4. Identification of DEGs between IR + NS and IR + Zymosan‐A groups {#jcmm13538-sec-0015}
---------------------------------------------------------------------

Using the RNA sequencing technology, total of 131 DEGs were identified (\[log2FoldChange\] \>.8 and *p*‐value \<.05), including 30 up‐regulated genes and 101 down‐regulated genes in the IR + Zymosan‐A groups, compared to IR + NS groups (Table [1](#jcmm13538-tbl-0001){ref-type="table-wrap"}). DEGs expression heat map was shown in Figure [4](#jcmm13538-fig-0004){ref-type="fig"}.

###### 

One hundred and thirty‐one differentially expressed genes (DEGs) were identified between IR + NS and IR + Zymosan‐A groups

  Up‐regulated gene   Down‐regulated gene                                                                       
  ------------------- --------------------- --------------- --------- --------- --------- ---------- ---------- ----------
  Stfa2               Ecm1                  Egr1            Herpud1   Ccrl2     Zc3h12a   Ier3       Irak2      Hbb‐b1
  Stfa3               Mir5109               Atf3            Gramd1a   Xcl1      Socs3     Lfng       H2‐K1      Beta‐s
  BC100530            F630028O10Rik         Ptafr           Lpl       Bpgm      Ier5      Cyth1      Cxcl2      Slc4a1
  BC117090            Gstm1                 Bcl3            Ptgs2     H2‐Q4     Tnf       Niacr1     Tnfsf13b   Mir21
  2010005H15Rik       Ear1                  Rasal3          Phf1      H2‐Q5     Erdr1     Txnip      Mir22      Hba‐a2
  Stfa1               Mt1                   Smox            Skil      Rasl11b   Nfkbia    H2‐Ab1     H2‐Eb1     Hba‐a1
  Gm5483              Rn45s                 Amica1          Cd74      Fmnl2     Mir24‐2   H2‐T22     Zfp36      Hbb‐b2
  Stfa2 l1            Ear12                 Neurl3          Nfkbid    Cables1   Relb      Nfkbiz     Nfkb2      Hbb‐bt
  Saa3                Ear3                  Ier2            Hmox1     Mir1901   Tnfaip3   H2‐T9      Ppp1r15a   Mirlet7i
  Mt2                 Ear7                  5430421N21Rik   Klf2      Tmcc2     Fn1       Junb       Smim5      Gpnmb
  Marco               Ear6                  Bbc3            Jund      H2‐Q6     H2‐Q10    Phlda1     Gabbr1     Mir146b
  Ggt1                Acvrl1                Irg1            H2‐Aa     H2‐Q8     Thbs1     Gm15441    Mir1198    
  Prok2               Ceacam10              Rnf167          Tgif1     H2‐Q9     Nfkbie    Jun        Dusp2      
  Lars2               Ctsg                  Pik3ap1         Tgm2      H2‐Q7     Gadd45b   Zmpste24   Antxr2     
  Steap4              Ear2                  Sh2b2           Sertad1   Alas2     Ptger4    Basp1      Ninj1      
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![Identification of differentially expressed genes (DEGs) between IR + NS and IR + Zymosan‐A groups. (A) Heat map of DEGs (30 up‐regulated genes and 101 down‐regulated genes. Red: up‐regulation; Green: down‐regulation). (B) Expression distribution of differential gene. (C) The scatter plots of DEGs (Red: up‐expressed gene; Green: down‐expressed gene; Grey: equally expressed gene).](JCMM-22-2413-g004){#jcmm13538-fig-0004}

3.5. DEGs gene ontology analysis between IR + NS and IR + Zymosan‐A groups {#jcmm13538-sec-0016}
--------------------------------------------------------------------------

Gene ontology analysis was used to investigate changes in the patterns of genes between IR + NS and IR + Zymosan‐A groups. The significantly enriched GO analysis of DEGs was shown in Table [2](#jcmm13538-tbl-0002){ref-type="table-wrap"} and Figure [5](#jcmm13538-fig-0005){ref-type="fig"}. The DEGs were classified into 3 functional groups: biological process group, cellular component group and molecular function group. The inflammatory response, nucleotide‐binding oligomerization domain containing 1 pathway and nucleotide‐binding oligomerization domain containing 2 pathways were significantly enriched in biological process group. The MHC class 1 protein complex, Golgi cisternae and endoplasmic reticulum exit site were significantly enriched in cellular component group. Within the molecular function group, the TAP binding, beta‐2‐microglobulin binding and peptide antigen binding were significantly enriched.

###### 

The differentially expressed genes were classified into 3 functional groups: biological process group, cellular component group and molecular function group

               Term                                                                                    Sample number   *P*‐value
  ------------ --------------------------------------------------------------------------------------- --------------- ------------
  GOBPID                                                                                                               
  GO:0006954   Inflammatory response                                                                   7               .000101907
  GO:0070427   Nucleotide‐binding oligomerization domain containing 1 signalling pathway               2               .000102889
  GO:0070431   Nucleotide‐binding oligomerization domain containing 2 signalling pathway               2               .000175861
  GO:0070423   Nucleotide‐binding oligomerization domain containing signalling pathway                 2               .000175861
  GO:0035872   Nucleotide‐binding domain, leucine rich repeat containing receptor signalling pathway   2               .000219501
  GO:0032495   Response to muramyl dipeptide                                                           2               .000320983
  GO:0045637   Regulation of myeloid cell differentiation                                              4               .000441585
  GO:0030099   Myeloid cell differentiation                                                            5               .000561916
  GO:0002753   Cytoplasmic pattern recognition receptor signalling pathway                             2               .000580165
  GO:0002682   Regulation of immune system process                                                     8               .00065509
  GOCCID                                                                                                               
  GO:0042612   MHC class I protein complex                                                             2               .000219501
  GO:0005797   Golgi medial cisterna                                                                   2               .000267882
  GO:0070971   Endoplasmic reticulum exit site                                                         2               .000267882
  GO:0042611   MHC protein complex                                                                     2               .000267882
  GO:0031985   Golgi cisternae                                                                         2               .004006148
  GO:0031984   Organelle subcompartment                                                                2               .00438872
  GO:0005795   Golgi stack                                                                             2               .008020845
  GO:0034364   High‐density lipoprotein particle                                                       1               .047761288
  GOMFID                                                                                                               
  GO:0046977   TAP binding                                                                             2               .000136983
  GO:0030881   Beta‐2‐microglobulin binding                                                            2               .000175861
  GO:0042608   T cell receptor binding                                                                 2               .000219501
  GO:0042605   Peptide antigen binding                                                                 2               .000441261
  GO:0042379   Chemokine receptor binding                                                              2               .004006148
  GO:0003823   Antigen binding                                                                         2               .00438872
  GO:0042277   Peptide binding                                                                         3               .009990679
  GO:0033218   Amide binding                                                                           3               .012628348
  GO:0035925   mRNA 3′‐UTR AU‐rich region binding                                                      1               .013258393
  GO:0016151   Nickel cation binding                                                                   1               .013258393
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![Gene ontology analysis and significant enriched GO terms of differentially expressed genes (DEGs) between IR + NS and IR + Zymosan‐A groups. GO analysis classified the DEGs into 3 groups (biological process group, molecular function group and cellular component group).](JCMM-22-2413-g005){#jcmm13538-fig-0005}

3.6. Signalling pathway enrichment analysis of DEGs between IR + NS and IR + Zymosan‐A groups {#jcmm13538-sec-0017}
---------------------------------------------------------------------------------------------

To further study the biological functions of the DEGs, KEGG analysis was used to evaluate the functions of the DEGs. The DEGs were mapped to 18 pathways in the KEGG database, as shown in Table [3](#jcmm13538-tbl-0003){ref-type="table-wrap"}. Moreover, the DEGs were classified into 5 classifications including cellular processes, environmental information, human diseases, metabolism and organismal systems (Figure [6](#jcmm13538-fig-0006){ref-type="fig"}). Within the environmental information group, TNF signalling pathway and NF‐kappa B signalling pathway were significantly enriched.

###### 

Signalling pathway enrichment analysis of differentially expressed genes between IR + NS and IR + Zymosan‐A groups

  Term                                   Id         Sample number   *P*‐value
  -------------------------------------- ---------- --------------- -----------
  Malaria                                mmu05144   7               9.88E‐08
  African trypanosomiasis                mmu05143   6               3.19E‐07
  Allograft rejection                    mmu05330   4               .000639
  Graft‐versus‐host disease              mmu05332   4               .000727
  Epstein‐Barr virus infection           mmu05169   7               .000801
  Type I diabetes mellitus               mmu04940   4               .000983
  TNF signalling pathway                 mmu04668   5               .001113
  Autoimmune thyroid disease             mmu05320   4               .001515
  Viral myocarditis                      mmu05416   4               .002323
  Antigen processing and presentation    mmu04612   4               .002648
  HTLV‐I infection                       mmu05166   7               .003374
  Herpes simplex infection               mmu05168   6               .003388
  NF‐kappa B signalling pathway          mmu04064   4               .005635
  Viral carcinogenesis                   mmu05203   6               .005662
  Phagosome                              mmu04145   5               .007443
  NOD‐like receptor signalling pathway   mmu04621   3               .008153
  Cell adhesion molecules (CAMs)         mmu04514   4               .025283
  Cyanoamino acid metabolism             mmu00460   1               .04628
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![Significant enriched GO terms of differentially expressed genes (DEGs) between IR + NS and IR + Zymosan‐A groups. KEGG analysis classified the DEGs into 5 groups (Cellular processes, environmental information, human diseases, metabolism and organismal systems).](JCMM-22-2413-g006){#jcmm13538-fig-0006}

4. DISCUSSION {#jcmm13538-sec-0018}
=============

Radiation‐induced death is a complex pathophysiological process.[6](#jcmm13538-bib-0006){ref-type="ref"}, [25](#jcmm13538-bib-0025){ref-type="ref"} The loss of BMC is the major reason of mice death after radiation. In previous study, we showed that the number of BMCs in mice treated with Zymosan‐A was higher than that in mice treated with NS.[19](#jcmm13538-bib-0019){ref-type="ref"} Using flow cytometry, we proved that Zymosan‐A inhibited apoptosis of BMCs induced by radiation, which contributed to the increased number of BMCs. Next, we detected the levels of GM‐CSF, G‐CSF, IL‐6 and IL‐12 in BMCs. Those cytokines play important roles in haematopoiesis.[26](#jcmm13538-bib-0026){ref-type="ref"}, [27](#jcmm13538-bib-0027){ref-type="ref"} For example, G‐CSF, which can stimulate the production of proteases that cleave many interactions including CXCR4/SDF‐1, has been used to induce HSC mobilization in current clinical practice.[28](#jcmm13538-bib-0028){ref-type="ref"} In addition, our unpublished experimental data revealed that Zymosan‐A also increased the number of LSK cells, which play critical roles in reconstitution of haematopoietic system after radiation.[29](#jcmm13538-bib-0029){ref-type="ref"}, [30](#jcmm13538-bib-0030){ref-type="ref"}

Ionizing radiation can lead to DNA damage through direct and indirect effects, including double‐strand breaks(DSB), single‐strand breaks(SSB), base mutation and deletion.[31](#jcmm13538-bib-0031){ref-type="ref"} Among them, DSB is the most serious consequence of cell, which can directly cause cell death and induce a series of inflammatory responses.[32](#jcmm13538-bib-0032){ref-type="ref"}, [33](#jcmm13538-bib-0033){ref-type="ref"} In our previous study, we found that Zymosan‐A can protected AHH‐1 form radiation‐induced apoptosis.[19](#jcmm13538-bib-0019){ref-type="ref"} By detecting γ‐H2AX, the marker of DSB damage, we showed that the DSB damage can be significantly reduced in Zymosan‐A‐treated group. This date reminded us that the radioprotection of Zymosan‐A can be achieved by reducing DSB.

RNA sequencing technology is highly accurate, rapid and effective. Using the RNA sequencing, 131 DEGs were identified finally and most of them were down‐regulated. Moreover, the DEGs were classified into 3 functional groups using GO analysis. And, many DEGs were enriched in the GO term of biological process group, especially evolved in the regulation of immune system process and inflammatory response. Our previous study revealed that Zymosan‐A protected the haematopoietic system from radiation‐induced damage via Toll‐Like Receptor 2. Thus, combining this study and our previous study, we concluded that Zymosan‐A might exhibit radioprotective effect through regulating immune system process and inflammatory response, in which TLR2 showed a key role KEGG analysis also supported this view, and showed that NOD‐like receptor signalling pathway, TNF signalling pathway and NF‐kappa B signalling pathway were significantly enriched in the environmental information group. Consistent with the finding using KEGG analysis, TNF and NF‐kappa B signalling pathway has been demonstrated that it was associated with radioprotection in our previous work.[17](#jcmm13538-bib-0017){ref-type="ref"} Thus, this study revealed the gene network of protective effects of Zymosan‐A.

In conclusion, Zymosan‐A exhibited great protective effects against ionizing radiation. Zymosan‐A protected bone marrow cells from radiation‐induced apoptosis, up‐regulated IL‐6, IL‐12, G‐CSF and GM‐CSF in BMCs. In addition, Zymosan‐A also protected cells from radiation‐induced DNA damage in vitro. Moreover, Zymosan‐A treatment induced 131 DEGs which were related to immune system process and inflammatory responses. These results provided new knowledge regarding the radioprotective effect of Zymosan‐A.
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